U.S. FDA Approves Bristol Myers Squibb’s Breyanzi
U.S. FDA Approves Bristol Myers Squibb’s Breyanzi ® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic…
Carbon
U.S. FDA Grants Accelerated Approval For Iovance’s Skin Cancer Therapy
Feb 16 (Reuters) - Iovance Biotherapeutics (IOVA.O), opens new tab said on Friday the U.S. health regulator has granted an accelerated approval for its cell therapy…
Ultragenyx has received FDA accelerated approval for Genglycos™
The first-ever treatment designed to address the underlying genetic cause of Glycogen Storage Disease Type Ia (GSDIa) = an ultra-rare, inherited metabolic disorder affecting…
Vertex, CRISPR’s Gene-Editing Therapy Casgevy Wins Early FDA Nod
he FDA has approved Vertex and CRISPR's gene-editing therapy Casgevy to treat beta thalassemia. Casgevy becomes the first therapy for the rare blood disorder…
Wellness Program RESET: What Employers Should Expect From Vendors
A recent report published by McKinsey estimates that poor health costs the U.S. economy about $3.2 trillion annually from premature deaths and the lost…
Yescarta Receives U.S. FDA Approval
Landmark ZUMA-7 Study Demonstrated Patients on Yescarta Were 2.5 Times More Likely to Be Alive at Two Years Without Cancer Progression or Need for…
